bimekizumab
ucb biopharma
['bimekizumab', 'hidradenitis']
#bimekizumab reduced the abscess and inflammatory nodule count better than placebo in patients with #hidradenitissuppurativa, according to a late-breaking session at #aad2023. 
Dermatology Times: The latest news and trends in dermatologic procedures, therapy, technology, products and drugs.